The Novel Oral Hsp90 Inhibitor NVP-HSP990 Exhibits Potent and Broad-spectrum Antitumor Activities In Vitro and In Vivo
MOLECULAR CANCER THERAPEUTICS (2012)
Journal
MOLECULAR CANCER THERAPEUTICS
Volume 11, Issue 3, Pages 730-739Publisher
AMER ASSOC CANCER RESEARCH
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
A dePEGylated Lipopeptide-Based Pan-Coronavirus Fusion Inhibitor Exhibits Potent and Broad-Spectrum Anti-HIV-1 Activity without Eliciting Anti-PEG Antibodies
Ling Xu, Chao Wang, Wei Xu, Lixiao Xing, Jie Zhou, Jing Pu, Mingming Fu, Lu Lu, Shibo Jiang, Qian Wang
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Dipyridyl-substituted thiosemicarbazone as a potent broad-spectrum inhibitor of metallo-β-lactamases
Jia-Qi Li, Han Gao, Le Zhai, Le-Yun Sun, Cheng Chen, Jia-Zhu Chigan, Huan-Huan Ding, Ke-Wu Yang
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
A Water-Soluble Antimony-Rich Polyoxometalate with Broad-Spectrum Antitumor Activities
Hui-Ping Xiao, Ya-Shuai Hao, Xin-Xiong Li, Peng Xu, Ming-Dong Huang, Shou-Tian Zheng
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)
XS-2, a novel potent dual PI3K/mTOR inhibitor, exhibits high in vitro and in vivo anti-breast cancer activity and low toxicity with the potential to inhibit the invasion and migration of triple-negative breast cancer
Shan Xu, Xin Sun, Leixuan Luo, Yang Yang, Qiuyan Guo, Sheng Tang, Zhiyan Jiang, Yuzhen Li, Jiaqian Han, Wenhui Gan, Feiyi Yang, Xuan Zhang, Yijun Liu, Chuanchuan Sun, Jie He, Meng Liu, Daiying Zuo, Wufu Zhu, Yingliang Wu
BIOMEDICINE & PHARMACOTHERAPY (2022)
Design, synthesis and biological evaluation of a new class of Hsp90 inhibitors vibsanin C derivatives
Meng Li, Xianlan She, Yufei Ou, Jiangxin Liu, Zaifeng Yuan, Qin-shi Zhao
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Design, synthesis, and biological evaluation of 2,4-diamino pyrimidine derivatives as potent FAK inhibitors with anti-cancer and anti-angiogenesis activities
Shan Wang, Rong-Hong Zhang, Hong Zhang, Yu-Chan Wang, Dan Yang, Yong-Long Zhao, Guo-Yi Yan, Guo-Bo Xu, Huan-Yu Guan, Yan-Hua Zhou, Dong-Bing Cui, Ting Liu, Yong-Jun Li, Shang-Gao Liao, Meng Zhou
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Smp24, a Scorpion-Venom Peptide, Exhibits Potent Antitumor Effects against Hepatoma HepG2 Cells via Multi-Mechanisms In Vivo and In Vitro
Tienthanh Nguyen, Ruiyin Guo, Jinwei Chai, Jiena Wu, Junfang Liu, Xin Chen, Mohamed A. Abdel-Rahman, Hu Xia, Xueqing Xu
TOXINS (2022)
Development of VER-50589 analogs as novel Hsp90 inhibitors
Xixi Fang, Jinhong Feng, Kewei Wang, Yepeng Luan
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2023)
HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias
Rony Mshaik, John Simonet, Aleksandra Georgievski, Layla Jamal, Shaliha Bechoua, Paola Ballerini, Pierre-Simon Bellaye, Zandile Mlamla, Jean-Paul Pais de Barros, Audrey Geissler, Pierre-Jean Francin, Francois Girodon, Carmen Garrido, Ronan Quere
BLOOD CANCER JOURNAL (2021)
A novel tumor-targeting strain of Xenorhabdus stockiae exhibits potent biological activities
Chao Zhang, Hanna Chen, Stephan Huettel, Shengbiao Hu, Wangyue Zhang, Xuezhi Ding, Jia Yin, Yulong Yin, Rolf Mueller, Liqiu Xia, Youming Zhang, Qiang Tu
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)
Identification of a novel acylthiourea-based potent broad-spectrum inhibitor for enterovirus 3D polymerase in vitro and in vivo
Xinjin Liu, Zhichao Xu, Jinsen Liang, Lei Yu, Pengyu Ren, Hai -Bing Zhou, Shuwen Wu, Ke Lan
ANTIVIRAL RESEARCH (2023)
A Low Membrane Hsp70 Expression in Tumor Cells With Impaired Lactate Metabolism Mediates Radiosensitization by NVP-AUY922
Melissa Schwab, Gabriele Multhoff
FRONTIERS IN ONCOLOGY (2022)
Total Synthesis of the Potent and Broad-Spectrum Antibiotics Amycolamicin and Kibdelomycin
Shaoqiang Yang, Chenglong Chen, Jie Chen, Chao Li
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)
ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model
Koen Vandyck, Rana Abdelnabi, Kusum Gupta, Dirk Jochmans, Andreas Jekle, Jerome Deval, Dinah Misner, Dorothee Bardiot, Caroline S. Foo, Cheng Liu, Suping Ren, Leonid Beigelman, Lawrence M. Blatt, Sandro Boland, Laura Vangeel, Steven Dejonghe, Patrick Chaltin, Arnaud Marchand, Vladimir Serebryany, Antitsa Stoycheva, Sushmita Chanda, Julian A. Symons, Pierre Raboisson, Johan Neyts
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
143D, a novel selective KRASG12C inhibitor exhibits potent antitumor activity in preclinical models
Lan-song Xu, Su-xin Zheng, Liang-he Mei, Ke-xin Yang, Ya-fang Wang, Qiang Zhou, Xiang-tai Kong, Ming-yue Zheng, Hua-liang Jiang, Cheng-ying Xie
ACTA PHARMACOLOGICA SINICA (2023)
Design and Discovery of N-(3-(2-(2-Hydroxyethoxy)-6morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide, a Selective, Efficacious, and Well-Tolerated RAF Inhibitor Targeting RAS Mutant Cancers: The Path to the Clinic
Savithri Ramurthy, Benjamin R. Taft, Robert J. Aversa, Paul A. Barsanti, Matthew T. Burger, Yan Lou, Gisele A. Nishiguchi, Alice Rico, Lina Setti, Aaron Smith, Sharadha Subramanian, Victoriano Tamez, Huw Tanner, Lifeng Wan, Cheng Hu, Brent A. Appleton, Mulugeta Mamo, Laura Tandeske, John E. Tellew, Shenlin Huang, Qn Yue, Apurva Cliaudliary, Hung Tian, Raman Iyer, A. Quamrul Hassan, Lesley A. Mathews Griner, Laura R. La Bonte, Vesselina G. Cooke, Anne Van Abbema, Hanne Merritt, Kalyani Gampa, Fei Feng, Jing Yuan, Yuji Mishina, Yingyun Wang, Jacob R. Haling, Sepideh Vaziri, Mohammad Hekmat-Nejad, Valery Polyakov, Richard Zang, Vijay Sethuraman, Payman Amiri, Mallika Singh, William R. Sellers, Emma Lees, Wenlin Shao, Michael P. Dillon, Darrin D. Stuart
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Quantitative Proteomics of the Cancer Cell Line Encyclopedia
David P. Nusinow, John Szpyt, Mahmoud Ghandi, Christopher M. Rose, E. Robert McDonald, Marian Kalocsay, Judit Jane-Valbuena, Ellen Gelfand, Devin K. Schweppe, Mark Jedrychowski, Javad Golji, Dale A. Porter, Tomas Rejtar, Y. Karen Wang, Gregory Kryukov, Frank Stegmeier, Brian K. Erickson, Levi A. Garraway, William R. Sellers, Steven P. Gygil
CELL (2020)
A Proof of Concept for Biomarker-Guided Targeted Therapy against Ovarian Cancer Based on Patient-Derived Tumor Xenografts
Adam C. Palmer, Deborah Plana, Hui Gao, Joshua M. Korn, Guizhi Yang, John Green, Xiamei Zhang, Roberto Velazquez, Margaret E. McLaughlin, David A. Ruddy, Colleen Kowal, Julie Muszynski, Caroline Bullock, Stacy Rivera, Daniel P. Rakiec, GiNell Elliott, Paul Fordjour, Ronald Meyer, Alice Loo, Esther Kurth, Jeffrey A. Engelman, Hans Bitter, William R. Sellers, Juliet A. Williams, Peter K. Sorger
CANCER RESEARCH (2020)
Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer
Matthew J. LaMarche, Michael Acker, Andreea Argintaru, Daniel Bauer, Julie Boisclair, Homan Chan, Christine Hiu-Tung Chen, Ying-Nan Chen, Zhouliang Chen, Zhan Deng, Michael Dore, David Dunstan, Jianmei Fan, Peter Fekkes, Brant Firestone, Michelle Fodor, Jorge Garcia-Fortanet, Pascal D. Fortin, Cary Fridrich, John Giraldes, Meir Glick, Denise Grunenfelder, Huia-Xiang Hao, Martin Hentemann, Samuel Ho, Andriana Jouk, Zhao B. Kang, Rajesh Karki, Mitsunori Kato, Nick Keen, Robert Koenig, Laura R. LaBonte, Jay Larrow, Gang Liu, Shumei Liu, Dyuti Majumdar, Simon Mathieu, Matthew J. Meyer, Morvarid Mohseni, Rukundo Ntaganda, Mark Palermo, Lawrence Perez, Minying Pu, Timothy Ramsey, John Reilly, Patrick Sarver, William R. Sellers, Martin Sendzik, Michael D. Shultz, Joanna Slisz, Kelly Slocum, Troy Smith, Stanley Spence, Travis Stams, Christopher Straub, Victoriano Tamez, Bakary-Barry Toure, Christopher Towler, Ping Wang, Hongyun Wang, Sarah L. Williams, Fan Yang, Bing Yu, Ji-Hu Zhang, Suzanne Zhu
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Targeted Covalent Inhibition of Plasmodium FK506 Binding Protein 35
Thomas C. Atack, Donald D. Raymond, Christa A. Blomquist, Charisse Flerida Pasaje, Patrick R. McCarren, Jamie Moroco, Henock B. Befekadu, Foxy P. Robinson, Debjani Pal, Lisl Y. Esherick, Alessandra Ianari, Jacquin C. Niles, William R. Sellers
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Targeting pan-essential genes in cancer: Challenges and opportunities
Liang Chang, Paloma Ruiz, Takahiro Ito, William R. Sellers
CANCER CELL (2021)
Discovery of a First-in-Class Inhibitor of the PRMT5-Substrate Adaptor Interaction
David C. McKinney, Brian J. McMillan, Matthew Ranaghan, Jamie A. Moroco, Merissa Brousseau, Zachary Mullin-Bernstein, Meghan O'Keefe, Patrick McCarren, Michael F. Mesleh, Kathleen M. Mulvaney, Foxy Robinson, Ritu Singh, Besnik Bajrami, Florence F. Wagner, Robert Hilgraf, Martin J. Drysdale, Arthur J. Campbell, Adam Skepner, David E. Timm, Dale Porter, Virendar K. Kaushik, William R. Sellers, Alessandra Ianari
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Molecular basis for substrate recruitment to the PRMT5 methylosome
Kathleen M. Mulvaney, Christa Blomquist, Nischal Acharya, Ruitong Li, Matthew J. Ranaghan, Meghan O'Keefe, Diego J. Rodriguez, Michael J. Young, Devishi Kesar, Debjani Pal, Matthew Stokes, Alissa J. Nelson, Sidharth S. Jain, Annan Yang, Zachary Mullin-Bernstein, Josie Columbus, Fazli K. Bozal, Adam Skepner, Donald Raymond, Salvatore LaRussa, David C. McKinney, Yelena Freyzon, Yossef Baidi, Dale Porter, Andrew J. Aguirre, Alessandra Ianari, Brian McMillan, William R. Sellers
MOLECULAR CELL (2021)
Are CRISPR Screens Providing the Next Generation of Therapeutic Targets?
Francisca Vazquez, William R. Sellers
CANCER RESEARCH (2021)
Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers
Takahiro Ito, Michael J. Young, Ruitong Li, Sidharth Jain, Andreas Wernitznig, John M. Krill-Burger, Christopher T. Lemke, Davide Monducci, Diego J. Rodriguez, Liang Chang, Sanjukta Dutta, Debjani Pal, Brenton R. Paolella, Michael V. Rothberg, David E. Root, Cory M. Johannessen, Laxmi Parida, Gad Getz, Francisca Vazquez, John G. Doench, Mahdi Zamanighomi, William R. Sellers
NATURE GENETICS (2021)
Comparative optimization of combinatorial CRISPR screens
Ruitong Li, Olaf Klingbeil, Davide Monducci, Michael J. Young, Diego J. Rodriguez, Zaid Bayyat, Joshua M. Dempster, Devishi Kesar, Xiaoping Yang, Mahdi Zamanighomi, Christopher R. Vakoc, Takahiro Ito, William R. Sellers
NATURE COMMUNICATIONS (2022)
Systematic profiling of conditional degron tag technologies for target validation studies
Daniel P. Bondeson, Zachary Mullin-Bernstein, Sydney Oliver, Thomas A. Skipper, Thomas C. Atack, Nolan Bick, Meilani Ching, Andrew A. Guirguis, Jason Kwon, Carly Langan, Dylan Millson, Brenton R. Paolella, Kevin Tran, Sarah J. Wie, Francisca Vazquez, Zuzana Tothova, Todd R. Golub, William R. Sellers, Alessandra Ianari
NATURE COMMUNICATIONS (2022)
Integrated CRISPR screening and drug profiling identifies combination opportunities for EGFR, ALK, and BRAF/MEK inhibitors
Ralph Tiedt, Frederick J. King, Christelle Stamm, Matthew J. Niederst, Scott Delach, Sabine Zumstein-Mecker, Jodi Meltzer, Iain J. Mulford, Emma Labrot, Barbara Schacher Engstler, Sabrina Baltschukat, Grainne Kerr, Javad Golji, Daniel Wyss, Christian Schnell, Edward Ainscow, Jeffrey A. Engelman, William R. Sellers, Jordi Barretina, Giordano Caponigro, Diana Graus Porta
CELL REPORTS (2023)
A highly multiplexed quantitative phosphosite assay for biology and preclinical studies
Hasmik Keshishian, E. Robert McDonald, Filip Mundt, Randy Melanson, Karsten Krug, Dale A. Porter, Luke Wallace, Dominique Forestier, Bokang Rabasha, Sara E. Marlow, Judit Jane-Valbuena, Ellen Todres, Harrison Specht, Margaret Lea Robinson, Pierre M. Jean Beltran, Ozgun Babur, Meagan E. Olive, Javad Golji, Eric Kuhn, Michael Burgess, Melanie A. MacMullan, Tomas Rejtar, Karen Wang, D. R. Mani, Shankha Satpathy, Michael A. Gillette, William R. Sellers, Steven A. Carr
MOLECULAR SYSTEMS BIOLOGY (2021)
Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders
Xuewei Wu, Xiaobao Yang, Yan Xiong, Ruitong Li, Takahiro Ito, Tamer A. Ahmed, Zoi Karoulia, Christos Adamopoulos, Hong Wang, Li Wang, Ling Xie, Jing Liu, Beatrix Ueberheide, Stuart A. Aaronson, Xian Chen, Sean G. Buchanan, William R. Sellers, Jian Jin, Poulikos I. Poulikakos
NATURE CANCER (2021)